{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:45:58Z","timestamp":1789501558675,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03524-w","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T11:16:29Z","timestamp":1732101389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lichenoid paraneoplastic pemphigus in a patient presenting with follicular lymphoma: a review of the literature"],"prefix":"10.1007","volume":"317","author":[{"given":"Kimberly N.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Milikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izidore S.","family":"Lossos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea D.","family":"Maderal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"3524_CR1","doi-asserted-by":"publisher","unstructured":"Adnani BO, O\u2019 Brien K, Myint ZW, Adler BL (2022) Paraneoplastic Pemphigus: A Striking Complication of Undiagnosed Lymphoma. Case Rep Hematol 2022:e3641474. https:\/\/doi.org\/10.1155\/2022\/3641474","DOI":"10.1155\/2022\/3641474"},{"key":"3524_CR2","doi-asserted-by":"publisher","unstructured":"Allison AC (2005) Mechanisms of action of mycophenolate mofetil. Lupus 14 suppl 1:s2-8. https:\/\/doi.org\/10.1191\/0961203305lu2109oa","DOI":"10.1191\/0961203305lu2109oa"},{"key":"3524_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1087-0024.2004.00832.x","volume":"9","author":"GJ Anhalt","year":"2004","unstructured":"Anhalt GJ (2004) Paraneoplastic pemphigus. J Investig Dermatol Symp Proc 9:29\u201333. https:\/\/doi.org\/10.1111\/j.1087-0024.2004.00832.x","journal-title":"J Investig Dermatol Symp Proc"},{"key":"3524_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/1346-8138.12095","volume":"40","author":"J Aoi","year":"2013","unstructured":"Aoi J, Makino K, Sakai K, Masuguchi S, Fukushima S, Jinnin M, Inoue Y, Koga H, Hashimoto T, Ihn H (2013) Case of paraneoplastic pemphigus with follicular lymphoma treated with rituximab. J Dermatol 40:285\u2013286. https:\/\/doi.org\/10.1111\/1346-8138.12095","journal-title":"J Dermatol"},{"key":"3524_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1468-3083.2005.01345.x","volume":"20","author":"M Barnadas","year":"2006","unstructured":"Barnadas M, Roe E, Brunet S, Garcia P, Bergua P, Pimentel L, Puig L, Francia A, Garc\u00eda R, Gelp\u00ed C, Sierra J, Coll P, Alomar A (2006) Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature. J Eur Acad Dermatol Venereol JEADV 20:69\u201374. https:\/\/doi.org\/10.1111\/j.1468-3083.2005.01345.x","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"3524_CR6","first-page":"269","volume":"137","author":"L Borradori","year":"2001","unstructured":"Borradori L, Lombardi T, Samson J, Girardet C, Saurat JH, H\u00fcgli A (2001) Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus. Arch Dermatol 137:269\u2013272","journal-title":"Arch Dermatol"},{"key":"3524_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/crj.13465","volume":"16","author":"W Chen","year":"2022","unstructured":"Chen W, Zhao L, Guo L, Zhao L, Niu H, Lian H, Dai H, Chen J, Wang C (2022) Clinical and pathological features of bronchiolitis obliterans requiring lung transplantation in paraneoplastic pemphigus associated with Castleman disease. Clin Respir J 16:173\u2013181. https:\/\/doi.org\/10.1111\/crj.13465","journal-title":"Clin Respir J"},{"key":"3524_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1365-4632.2004.02526.x","volume":"44","author":"S Coelho","year":"2005","unstructured":"Coelho S, Reis JP, Tellechea O, Figueiredo A, Black M (2005) Paraneoplastic pemphigus with clinical features of lichen planus associated with low-grade B cell lymphoma. Int J Dermatol 44:366\u2013371. https:\/\/doi.org\/10.1111\/j.1365-4632.2004.02526.x","journal-title":"Int J Dermatol"},{"key":"3524_CR9","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3389\/fimmu.2019.01418","volume":"10","author":"D Didona","year":"2019","unstructured":"Didona D, Maglie R, Eming R, Hertl M (2019) Pemphigus: current and future therapeutic strategies. Front Immunol 10:1418. https:\/\/doi.org\/10.3389\/fimmu.2019.01418","journal-title":"Front Immunol"},{"key":"3524_CR10","doi-asserted-by":"publisher","unstructured":"Heizmann M, Itin P, Wernli M, Borradori L, Bargetzi MJ (2001) Successful treatment of paraneoplastic pemphigus in follicular NHL with Rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL. Am J Hematol 66:142\u2013144. https:\/\/doi.org\/10.1002\/1096-8652(200102)66:2%3C142::AID-AJH1032%3E3.0.CO;2-0","DOI":"10.1002\/1096-8652(200102)66:2%3C142::AID-AJH1032%3E3.0.CO;2-0"},{"key":"3524_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00277-014-2202-1","volume":"94","author":"T Higo","year":"2015","unstructured":"Higo T, Miyagaki T, Nakamura F, Shinohara A, Asano H, Abe H, Senda N, Yoshizaki A, Fukayama M, Kurokawa M (2015) Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma. Ann Hematol 94:683\u2013685. https:\/\/doi.org\/10.1007\/s00277-014-2202-1","journal-title":"Ann Hematol"},{"key":"3524_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3960\/jslrt.55.83","volume":"55","author":"T Hirano","year":"2015","unstructured":"Hirano T, Higuchi Y, Yuki H, Hirata S, Nosaka K, Ishii N, Hashimoto T, Mitsuya H, Okuno Y (2015) Rituximab Monotherapy and Rituximab-Containing Chemotherapy were effective for paraneoplastic Pemphigus Accompanying Follicular Lymphoma, but not for subsequent bronchiolitis Obliterans. J Clin Exp Hematop JCEH 55:83\u201388. https:\/\/doi.org\/10.3960\/jslrt.55.83","journal-title":"J Clin Exp Hematop JCEH"},{"key":"3524_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1365-2230.2006.02331.x","volume":"32","author":"SR Hoque","year":"2007","unstructured":"Hoque SR, Black MM, Cliff S (2007) Paraneoplastic pemphigus associated with CD20-positive follicular non-hodgkin\u2019s lymphoma treated with rituximab: a third case resistant to rituximab therapy. Clin Exp Dermatol 32:172\u2013175. https:\/\/doi.org\/10.1111\/j.1365-2230.2006.02331.x","journal-title":"Clin Exp Dermatol"},{"key":"3524_CR14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s12288-016-0689-4","volume":"32","author":"A Jain","year":"2016","unstructured":"Jain A, Prakash G, Nampoothiri RV, De D, Bal A, Khadwal A, Lad D, Malhotra P, Varma S (2016) Peri-anal paraneoplastic Pemphigus heralding the relapse of Follicular Lymphoma and its successful management by Rituximab: a short correspondence. Indian J Hematol Blood Transfus 32:519\u2013521. https:\/\/doi.org\/10.1007\/s12288-016-0689-4","journal-title":"Indian J Hematol Blood Transfus"},{"key":"3524_CR15","volume-title":"Paraneoplastic Pemphigus","author":"RH Kappius","year":"2024","unstructured":"Kappius RH, Ufkes NA, Thiers BH (2024) Paraneoplastic Pemphigus. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"3524_CR16","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3389\/fimmu.2019.01259","volume":"10","author":"JH Kim","year":"2019","unstructured":"Kim JH, Kim S-C (2019) Paraneoplastic Pemphigus: paraneoplastic autoimmune disease of the skin and Mucosa. Front Immunol 10:1259. https:\/\/doi.org\/10.3389\/fimmu.2019.01259","journal-title":"Front Immunol"},{"key":"3524_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.5021\/ad.2021.33.3.271","volume":"33","author":"M Kim","year":"2021","unstructured":"Kim M, Lee JY, Kim S-C, Na J-I (2021) A case of Paraneoplastic Pemphigus as a Preceding Manifestation of underlying follicular lymphoma treated with R-CHOP. Ann Dermatol 33:271\u2013274. https:\/\/doi.org\/10.5021\/ad.2021.33.3.271","journal-title":"Ann Dermatol"},{"key":"3524_CR18","doi-asserted-by":"publisher","first-page":"5808","DOI":"10.2340\/00015555-3557","volume":"100","author":"KOKUBUH NISHIKAWA","year":"2020","unstructured":"NISHIKAWA KOKUBUH, KATO J, MUKAISHO T, HAYASHI K, TATEISHI D, TSURUTA C, HASHIMOTO D, TANAKA T, FUJIMOTO T N (2020) Paraneoplastic Pemphigus Mimicking Toxic Epidermal Necrolysis Associated with follicular lymphoma: possible pathological role of CD8 T cells. Acta Derm Venereol 100:5808. https:\/\/doi.org\/10.2340\/00015555-3557","journal-title":"Acta Derm Venereol"},{"key":"3524_CR19","doi-asserted-by":"publisher","first-page":"100813","DOI":"10.1016\/j.currproblcancer.2021.100813","volume":"46","author":"K Kuriyama","year":"2022","unstructured":"Kuriyama K, Kitamura Y, Tsuji T, Nishikawa R, Nagata H, Ohshiro M, Sugitani M, Hirakawa Y, Matsumoto Y, Iwai T, Uchiyama H (2022) Successful treatment of paraneoplastic pemphigus and bronchiolitis obliterans associated with follicular lymphoma with obinutuzumab and bendamustine. Curr Probl Cancer 46:100813. https:\/\/doi.org\/10.1016\/j.currproblcancer.2021.100813","journal-title":"Curr Probl Cancer"},{"key":"3524_CR20","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2141.2008.07388.x","volume":"144","author":"F Lachenal","year":"2009","unstructured":"Lachenal F, Amini M, Salino S, Biron P (2009) Paraneoplastic pemphigus associated with follicular lymphoma. Br J Haematol 144:458\u2013458. https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07388.x","journal-title":"Br J Haematol"},{"key":"3524_CR21","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1007\/s12185-017-2305-2","volume":"106","author":"S Lee","year":"2017","unstructured":"Lee S, Yamauchi T, Ishii N, Hashimoto T, Kinoshita K, Imamura S, Kamiya K (2017) Achievement of the longest survival of paraneoplastic pemphigus with bronchiolitis obliterans associated with follicular lymphoma using R-CHOP chemotherapy. Int J Hematol 106:852\u2013859. https:\/\/doi.org\/10.1007\/s12185-017-2305-2","journal-title":"Int J Hematol"},{"key":"3524_CR22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/ced.13563","volume":"43","author":"JM Lim","year":"2018","unstructured":"Lim JM, Kim JH, Hashimoto T, Kim S-C (2018) Lichenoid paraneoplastic pemphigus associated with follicular lymphoma without detectable autoantibodies. Clin Exp Dermatol 43:613\u2013615. https:\/\/doi.org\/10.1111\/ced.13563","journal-title":"Clin Exp Dermatol"},{"key":"3524_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/00015550510025542","volume":"85","author":"MI De Mart\u00ednez","year":"2005","unstructured":"De Mart\u00ednez MI, Iranzo P, Mascar\u00f3 JM, Llambrich A, Baradad M, Herrero C (2005) Paraneoplastic pemphigus associated with non-hodgkin B-cell lymphoma and good response to prednisone. Acta Derm Venereol 85:233\u2013235. https:\/\/doi.org\/10.1080\/00015550510025542","journal-title":"Acta Derm Venereol"},{"key":"3524_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1590\/abd1806-4841.20199165","volume":"94","author":"CW Maruta","year":"2019","unstructured":"Maruta CW, Miyamoto D, Aoki V, de Carvalho RGR, Cunha BM, Santi CG (2019) Paraneoplastic pemphigus: a clinical, laboratorial, and therapeutic overview. Bras Dermatol 94:388. https:\/\/doi.org\/10.1590\/abd1806-4841.20199165","journal-title":"Bras Dermatol"},{"key":"3524_CR25","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","volume":"16","author":"P McLaughlin","year":"1998","unstructured":"McLaughlin P, Grillo-L\u00f3pez AJ, Link BK, Levy R, Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I, White CA, Cabanillas F, Jain V, Ho AD, Lister J, Wey K, Shen D, Dallaire BK (1998) Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol off J Am Soc Clin Oncol 16:2825\u20132833. https:\/\/doi.org\/10.1200\/JCO.1998.16.8.2825","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"key":"3524_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000357109","volume":"132","author":"K Morikawa","year":"2014","unstructured":"Morikawa K, Tsuji T, Yamasaki H, Egashira S, Kaguchi A, Kido M, Tsuda H (2014) Paraneoplastic pemphigus occurs most commonly in indolent B cell lymphoma. Acta Haematol 132:73\u201374. https:\/\/doi.org\/10.1159\/000357109","journal-title":"Acta Haematol"},{"key":"3524_CR27","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/ajh.23471","volume":"88","author":"MA Moustafa","year":"2013","unstructured":"Moustafa MA, Seningen JL, Jouni H, Singh PP, el-Azhary RA, Witzig TE (2013) A skin rash and what lies beneath: paraneoplastic pemphigus, an atypical presentation of follicular cell lymphoma. Am J Hematol 88:822\u2013823. https:\/\/doi.org\/10.1002\/ajh.23471","journal-title":"Am J Hematol"},{"key":"3524_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09546630802032603","volume":"19","author":"EM Prodanovic","year":"2008","unstructured":"Prodanovic EM, Korman NJ (2008) A case of Non-hodgkin\u2019s lymphoma-associated pemphigus foliaceus and use of Rituximab for treatment. J Dermatol Treat 19:1\u20133. https:\/\/doi.org\/10.1080\/09546630802032603","journal-title":"J Dermatol Treat"},{"key":"3524_CR29","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/cup.14004","volume":"48","author":"SA Svoboda","year":"2021","unstructured":"Svoboda SA, Huang S, Liu X, Hsu S, Motaparthi K (2021) Paraneoplastic pemphigus: revised diagnostic criteria based on literature analysis. J Cutan Pathol 48:1133\u20131138. https:\/\/doi.org\/10.1111\/cup.14004","journal-title":"J Cutan Pathol"},{"key":"3524_CR30","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1046\/j.1365-2133.2000.03365.x","volume":"142","author":"JV Williams","year":"2000","unstructured":"Williams JV, Marks JG, Billingsley EM (2000) Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus. Br J Dermatol 142:506\u2013508. https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03365.x","journal-title":"Br J Dermatol"},{"key":"3524_CR31","first-page":"1915","volume":"13","author":"S Wu","year":"2020","unstructured":"Wu S, Gao D, Zhang Y, Yang P, Wang Y, Wang N, Xu J, Yu G (2020) Follicular lymphoma with paraneoplastic pemphigus as the first symptom: a case report and review of the literature. Int J Clin Exp Pathol 13:1915","journal-title":"Int J Clin Exp Pathol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03524-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03524-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03524-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T12:02:53Z","timestamp":1732104173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03524-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3524"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03524-w","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients signed informed consent regarding publishing their data and photographs.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}